To LP or not to LP? Identifying the Etiology of Pediatric Meningitis

Hana Mijovic1, Manish Sadarangani2

  • 1Department of Pediatrics, University of British Columbia.

Insights

Conjugate vaccines have reduced bacterial meningitis in children. Cerebrospinal fluid analysis is crucial for diagnosing meningitis, distinguishing bacterial from viral causes, and guiding appropriate treatment, avoiding unnecessary antibiotics.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Microbiology

Background:

  • Conjugate vaccines for Haemophilus influenzae type b, Streptococcus pneumoniae, and Neisseria meningitidis have significantly decreased bacterial meningitis incidence in vaccinated children.
  • Viral meningitis is now the predominant cause of meningitis in hospitalized children in high-income nations, often not requiring antibiotic therapy.

Purpose of the Study:

  • To provide an overview of acute bacterial and viral meningitis in children.
  • To discuss the evolving epidemiology of pediatric meningitis.
  • To evaluate diagnostic methods for meningitis and inform clinical practice.

Main Methods:

  • Review of current literature on pediatric meningitis epidemiology and diagnostics.
  • Analysis of the role of cerebrospinal fluid analysis in diagnosis and management.
  • Discussion of conventional and novel diagnostic techniques for pathogen detection.

Main Results:

  • Vaccination has shifted the landscape of meningitis, with viral causes becoming more common.
  • Cerebrospinal fluid analysis remains essential for accurate diagnosis and appropriate treatment decisions.
  • Advanced diagnostic tests enhance pathogen identification in cerebrospinal fluid.

Conclusions:

  • Prompt lumbar puncture is critical when meningitis is suspected.
  • Accurate diagnosis via CSF analysis prevents unnecessary antibiotic use and hospitalization for viral meningitis.
  • Understanding current epidemiology and diagnostic capabilities is key for managing pediatric meningitis.

Related Concept Videos

Cranial and Spinal Meninges01:19

Cranial and Spinal Meninges

The cranial and spinal meninges are complex protective structures surrounding the central nervous system (CNS), consisting of the brain and spinal cord. These meninges consist of the dura mater, the arachnoid mater, and the pia mater. They protect the CNS, provide structural support, and aid in circulating cerebrospinal fluid (CSF).
Cranial Meninges
These meningeal layers cover the cranium. The dura mater is the outermost layer of cranial meninges. It is a thick and durable membrane of dense...
3.7K
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
462
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
271
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
199
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
260